Coombs'-positive hemolytic disease in malaria.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D000906:Antibodies / Q000032:analysis; D002738:Chloroquine / Q000627:therapeutic use; D003298:Coombs Test; D003875:Drug Eruptions / Q000150:complications; D004352:Drug Resistance, Microbial; D004912:Erythrocytes / Q000276:immunology; D006400:Hematocrit; D006801:Humans; D008288:Malaria / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000009:adverse effects; D013411:Sulfadiazine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D013411:Sulfadiazine; D002738:Chloroquine; D011803:Quinine; D011739:Pyrimethamine